Company: BLCO
Filing Date: 2025-02-19
Form Type: 10-K
Source: 0001860742-25-000004
Chunk: 419

Company: Bausch & Lomb Corp
Filing Date: 2025-02-19
Form: 10-K
Item: Item 1A
Chunk 419
---
 allocation decisions for each of its segments. Segment profit is based on operating income after the elimination of intercompany transactions. Certain costs, such as Amortization of intangible assets, and Other expense, net, are not included in the measure of segment profit, as management excludes these items in assessing segment financial performance.Corporate includes the finance, treasury, certain research and development programs, tax and legal operations of Bausch + Lomb’s businesses and incurs certain expenses, gains and losses related to the overall management of Bausch + Lomb, which are not allocated to the other business segments. In assessing segment performance and managing operations, management does not review segment assets. Furthermore, a portion of share-based compensation is considered a corporate cost, since the 

F-59

amount of such expense depends on company-wide performance rather than the operating performance of any single segment.Segment Revenues and ProfitSegment revenues and profits for the years 2024, 2023 and 2022 were as follows:Vision CarePharmaceuticalsSurgicalTotal(in millions)202420232022202420232022202420232022202420232022RevenuesProduct Sales$2,731 $2,535 $2,362 $1,206 $834 $678 $837 $762 $706 $4,774 $4,131 $3,746 Other Revenues8 8 7 3 2 3 6 5 12 17 15 22 2,739 2,543 2,369 1,209 836 681 843 767 718 4,791 4,146 3,768 ExpensesCost of goods sold (excluding amortization and impairments of intangible assets)1,002 954 892 374 252 217 492 434 402 Cost of other revenues1 1 1 3 1 2 — — 5 Selling, general and administrative882 832 784 543 322 230 265 248 231 Research and development46 67 56 33 20 29 42 35 38 Segment Profit$808 $689 $636 $256 $241 $203 $44 $50 $42 1,108 980 881 Corporate(614)(536)(417)Amortization of intangible assets(288)(